AI assistant
OMNICELL, INC. — Director's Dealing 2025
Mar 11, 2025
31980_dirs_2025-03-11_9c4b9a60-bace-4bb8-a852-7b159774e2ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OMNICELL, INC. (OMCL)
CIK: 0000926326
Period of Report: 2025-03-08
Reporting Person: Etta Nchacha (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-08 | Common Stock | A | 66633 | — | Acquired | 137391 | Direct |
| 2025-03-08 | Common Stock | F | 5368 | $36.99 | Disposed | 132023 | Direct |
Footnotes
F1: Reflects performance-based restricted stock units that were previously granted on February 27, 2024, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 8, 2025 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 66,633 performance-based restricted stock units (176% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).
F2: Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units.